CALL US: 206.533.3854
CALL US  206.533.3854
AEON Law logo full color transparent
AEON law logo on grey background

Licensee’s Customers NOT Required to Pay Royalties

Exhausted patents
Still yield fruit in the future
For those who use them.

In a key decision late last month, the U.S. Supreme Court declined to hear the Tessera v. ITC et al patent infringement case, where the issues in dispute included the validity of the patent for a semiconductor packaging method, the licensing of said method, and patent exhaustion in relation licenses of the method. In 2007, Tessera had brought claims accusing 10 respondents of infringing on its patents for several methods of packaging semiconductor chips.

Tessera’s patent infringement and patent rights claims were not much in dispute, although Tessera did argue in support of both.  The key issues before the Court were when Tessera’s patent rights would be exhausted, and against whom could Tessera bring a claim.  Although the majority of respondents had licenses to sell the products, the relevant licenses all included a clause that said “Licensee is licensed only to Licensed Products for which Licensee or a third party has satisfied a royalty obligation of Tessera.” Tessera brought claims against product purchasers who had bought patented products from Tessera licensees.  The relevant licensees were not up-to-date on their royalties, and Tessera argued that during the time that royalties were unpaid, Tessera’s patent rights were not exhausted.

Tessera’s position that a licensee’s sale of a patented product was unauthorized if the licensor, in this case Tessera, had not received the royalties, was found to be “unpersuasive” by the Federal Circuit.  The court also said that Tessera should seek unpaid royalties from their licensees, not their licensees’ customers. The special provision in Tessera’s licenses, therefore, which requires licensees to pay royalties to avoid being held liable for patent infringement, did not create liability in either the licensees or subsequent users of the patented item. The Federal Circuit had held that permitting such clauses to stand would be “wholly inconsistent with the fundamental purpose of patent exhaustion—to prohibit post-sale restrictions on the use of a patented article.” Slip op. at 23.

Therefore, it is likely that with the US Supreme Court declining to hear the case, such clauses will not be of much use going forward.

NOTE: Additional findings of the Federal Circuit included no infringement by the wBGA products.  The Court affirmed the finding that none of the offered references anticipate the asserted claims of the ’106 patent, which had been appealed by the respondents. The court further held that due to the ’977 and ’627 patents expiring, the related infringement claims were moot.

Related Articles

Federal Circuit Affirms Blockchain Gem Patent Is Invalid

The Federal Circuit has affirmed a lower court’s decision finding the claims of a patent for preventing gemstone counterfeiting invalid. The case is Rady v. ...
Read More

Tennessee Passes Law Against AI Voice Copies

The state of Tennessee has passed a law against the use of artificial intelligence (AI) to copy a person’s voice. The law, signed on March ...
Read More

Bill Proposes IP Protection for Golf Courses

Congressmen Brian Fitzpatrick (R-PA) and Jimmy Panetta (D-CA) have introduced the Bolstering Intellectual Rights against Digital Infringement Enhancement (a.k.a. the BIRDIE Act), which proposes amending ...
Read More

Let's work together.

Contact us to set up a meeting with an attorney or team member.

Stay Informed

Sign up to receive Patent Poetry—a monthly roundup of key IP issues in our signature haiku format. Four articles (only 68 syllables); zero hassle.

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

SERVICES

PROTECT

DEAL

DEFEND